Spruce Biosciences to Participate in May Investor Conferences

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $SPRB–Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that company management will participate in two upcoming investor conferences taking place in May. The JMP Securities Life…

Advertisement — Advertise with Biotech Networks